Joshua Goldstein

Follow

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Nucleic acids encoding lectin-like oxidized LDL receptor 1 antibodies
- Patent number 10,870,698
- Issue date Dec 22, 2020
- Novartis AG
- Kurt Alex Heldwein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating cardiovascular disorders with lectin-like oxidi...
- Patent number 9,982,046
- Issue date May 29, 2018
- Novartis AG
- Kurt Alex Heldwein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Lectin-like oxidized LDL receptor 1 antibodies and methods of use
- Patent number 9,512,222
- Issue date Dec 6, 2016
- Novartis AG
- Kurt Alex Heldwein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
LECTIN-LIKE OXIDIZED LDL RECEPTOR 1 ANTIBODIES AND METHODS OF USE
- Publication number 20190040128
- Publication date Feb 7, 2019
- Novartis AG
- Kurt Alex HELDWEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LECTIN-LIKE OXIDIZED LDL RECEPTOR 1 ANTIBODIES AND METHODS OF USE
- Publication number 20170152313
- Publication date Jun 1, 2017
- Novartis AG
- Kurt Alex HELDWEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LECTIN-LIKE OXIDIZED LDL RECEPTOR 1 ANTIBODIES AND METHODS OF USE
- Publication number 20150004168
- Publication date Jan 1, 2015
- IRM LLC
- Kurt Alex HELDWEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PCSK9 ANTAGONISTS
- Publication number 20130315927
- Publication date Nov 28, 2013
- Novartis AG
- Joshua Goldstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE